A cellular model for screening neuronal nitric oxide synthase inhibitors

Area of Science:

• Biochemistry
• Pharmacology
• Cell Biology

Background:

• Excessive nitric oxide (NO) production is implicated in various diseases.
• In vitro screening of nitric oxide synthase (NOS) inhibitors using recombinant enzymes has identified potent compounds.
• A gap exists between in vitro findings and in vivo relevance for NOS inhibitor studies.

Purpose of the Study:

• To develop a physiologically relevant cellular model for screening nitric oxide synthase (NOS) inhibitors.
• To bridge the gap between in vitro assays and in vivo studies for NOS inhibition.
• To establish a versatile and sensitive assay for evaluating NOS inhibitor bioavailability.

Main Methods:

• Overexpression of rat neuronal nitric oxide synthase (NOS) in HEK 293T cells to create stable transformants.
• Activation of NOS by intracellular calcium ion introduction.
• Quantification of nitrite, a stable product of NO, in the culture medium using the Griess reagent to measure enzyme activity.

Main Results:

• The developed cell-based assay demonstrated sensitivity, versatility, and ease of use.
• The assay successfully identified and evaluated known NOS inhibitors.
• The cell-based system provides insights into inhibitor bioavailability, which is not possible with in vitro methods.

Conclusions:

• The novel cell-based assay offers a more physiologically relevant platform for screening NOS inhibitors compared to traditional in vitro methods.
• This assay is suitable for high-throughput screening and provides crucial data on inhibitor bioavailability.
• The developed model aids in the discovery and development of potential therapeutic agents targeting diseases associated with excessive NO production.